Doctor profile · Federal record

Dr. Naval Daver, MBBS

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Houston, TX

  • NPI 1740422823
  • Accepts Medicare
  • MIPS 79.4 / 100 · 2023
  • 22 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1515 Holcombe Blvd
Houston, TX 770304009
(713) 794-4392
Mailing address
Po Box 4439
Houston, TX 772104439

Credentials & registration

NPPES · NUCC
NPI registered
April 2009 — 17 yrs on file
Profile last updated
July 10, 2012
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #P0031
Medicaid
TX #283989601

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740422823. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
718
Distinct HCPCS
5
Medicare allowed
$92,642
HCPCS Description Services Patients Avg allowed
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 440 86 $120
99215 Established patient office or other outpatient visit, 40-54 minutes 188 64 $145
99205 New patient office or other outpatient visit, 60-74 minutes 41 40 $184
99214 Established patient office or other outpatient visit, 30-39 minutes 38 23 $97
99239 Hospital discharge day management, more than 30 minutes 11 11 $116

In context: peer comparison

Among 79 peers in this city , average services per provider: 1,097. This provider delivers 0.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$140,016
Transactions
103
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo Inc. 39 $34,958.90
Astellas Pharma Europe Ltd 4 $32,735.35
Sumitomo Pharma Co., Ltd. 17 $31,482.90
Hikma Pharmaceuticals USA 3 $16,320.00
Astellas Pharma US Inc 8 $6,634.99
SANOFI US SERVICES INC. 1 $3,739.50
Sumitomo Pharma America, Inc. 7 $3,041.90
Adaptive Biotechnologies Corporation 1 $2,400.00
SERVIER PHARMACEUTICALS LLC 1 $2,222.50
MITSUBISHI TANABE PHARMA AMERICA, INC. 2 $2,180.00
Astellas Pharma Inc 2 $1,691.23
Regeneron Pharmaceuticals, Inc. 1 $1,246.50
Rigel Pharmaceuticals, Inc. 5 $452.20
ABBVIE INC. 6 $421.28
Genentech USA, Inc. 6 $239.21

By nature of payment

Consulting Fee
$63,687
Travel and Lodging
$53,175
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$10,770
Honoraria
$8,473
Food and Beverage
$3,911

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
116
Patients
44
Total drug cost
$71,486
Drug Type Claims Patients Total cost
Venclexta (Venetoclax) Brand 51 21 $49,132
Levofloxacin Generic 19 11 $216
Valacyclovir (Valacyclovir Hcl) Brand 18 12 $535
Cefpodoxime Proxetil Generic 15 0 $4,167
Posaconazole Generic 13 0 $17,435

Frequently asked questions

Auto-generated from federal data
What is Dr. Naval Daver's medical specialty?
Dr. Naval Daver practices Hematology & Oncology Physician in Houston, TX.
Where does Dr. Naval Daver practice?
Dr. Naval Daver practices at 1515 Holcombe Blvd, Houston, TX 770304009. Office phone: 7137944392.
What is Dr. Naval Daver's NPI?
Dr. Naval Daver's National Provider Identifier (NPI) is 1740422823, issued by NPPES.
Does Dr. Naval Daver accept Medicare assignment?
Yes. Dr. Naval Daver accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Naval Daver commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.